Please use this identifier to cite or link to this item: https://repository.monashhealth.org/monashhealthjspui/handle/1/31720
Full metadata record
DC FieldValueLanguage
dc.contributor.authorWu F.C.W.en
dc.contributor.authorVogelsong K.en
dc.contributor.authorWang X.-H.en
dc.contributor.authorZitzmann M.en
dc.contributor.authorWang C.en
dc.contributor.authorHandelsman D.J.en
dc.contributor.authorLiu P.Y.en
dc.contributor.authorSwerdloff R.S.en
dc.contributor.authorAnawalt B.D.en
dc.contributor.authorAnderson R.A.en
dc.contributor.authorBremner W.J.en
dc.contributor.authorElliesen J.en
dc.contributor.authorGu Y.-Q.en
dc.contributor.authorKersemaekers W.M.en
dc.contributor.authorMcLachlan R.I.en
dc.contributor.authorMeriggiola M.C.en
dc.contributor.authorNieschlag E.en
dc.contributor.authorSitruk-Ware R.en
dc.date.accessioned2021-05-14T10:44:05Zen
dc.date.available2021-05-14T10:44:05Zen
dc.date.copyright2008en
dc.date.created20080619en
dc.date.issued2012-10-16en
dc.identifier.citationJournal of Clinical Endocrinology and Metabolism. 93 (5) (pp 1774-1783), 2008. Date of Publication: May 2008.en
dc.identifier.issn0021-972Xen
dc.identifier.urihttps://repository.monashhealth.org/monashhealthjspui/handle/1/31720en
dc.description.abstractContext: Male hormonal contraceptive methods require effective suppression of sperm output. Objective(s): The objective of the study was to define the covariables that influence the rate and extent of suppression of spermatogenesis to a level shown in previous World Health Organization-sponsored studies to be sufficient for contraceptive purposes (<=1 million/ml). Design(s): This was an integrated analysis of all published male hormonal contraceptive studies of at least 3 months' treatment duration. Setting(s): Deidentified individual subject data were provided by investigators of 30 studies published between 1990 and 2006. Participant(s): A total of 1756 healthy men (by physical, blood, and semen exam) aged 18-51 yr of predominantly Caucasian (two thirds) or Asian (one third) descent were studied. This represents about 85% of all the published data. Intervention(s): Men were treated with different preparations of testosterone, with or without various progestins. Main Outcome Measure(s): Semen analysis was the main measure. Result(s): Progestin coadministration increased both the rate and extent of suppression. Caucasian men suppressed sperm output faster initially but ultimately to a less complete extent than did non-Caucasians. Younger age and lower initial blood testosterone or sperm concentration were also associated with faster suppression, but the independent effect sizes for age and baseline testicular function were relatively small. Conclusion(s): Male hormonal contraceptives can be practically applied to a wide range of men but require coadministration of an androgen with a second agent (i.e. progestin) for earlier and more complete suppression of sperm output. Whereas considerable progress has been made toward defining clinically effective combinations, further optimization of androgen-progestin treatment regimens is still required. Copyright © 2008 by The Endocrine Society.en
dc.languageEnglishen
dc.languageenen
dc.publisherEndocrine Society (8401 Connecticut Ave. Suite 900, Chevy Chase MD 20815, United States)en
dc.titleDeterminants of the rate and extent of spermatogenic suppression during hormonal male contraception: An integrated analysis.en
dc.typeArticleen
dc.identifier.doihttp://monash.idm.oclc.org/login?url=http://dx.doi.org/10.1210/jc.2007-2768en
dc.publisher.placeUnited Statesen
dc.identifier.pubmedid18303073 [http://www.ncbi.nlm.nih.gov/pubmed/?term=18303073]en
dc.identifier.source351656517en
dc.identifier.institution(Liu, Handelsman) Department of Andrology, ANZAC Research Institute, Concord Hospital, Concord, NSW 2139, Australia (Swerdloff) Division of Endocrinology, Department of Medicine, LABiomed and Harbor-UCLA Medical Center, Torrance, CA 90509, United States (Anawalt) Department of Medicine, Veterans Affairs Puget Sound Health Care System, University of Washington, Seattle, WA 98195, United States (Anderson) Division of Reproductive and Developmental Sciences, Queen's Medical Research Institute, University of Edinburgh, Edinburgh EH16 4TJ, United Kingdom (Bremner) Department of Medicine, University of Washington, Seattle, WA 98195, United States (Elliesen) Bayer Schering Pharma AG, 93 HRB 283 Berlin, Germany (Gu) Department of Endocrinology, National Research Institute for Family Planning, Beijing 100081, China (Kersemaekers) Translational Medicine Department, N.V. Organon, Schering-Plough Corporation, Oss NL-5340 BH, Netherlands (McLachlan) Prince Henry's Institute, Monash Medical Centre, Monash University, Clayton, VIC 3168, Australia (Meriggiola) Departments of Obstetrics and Gynecology, S. Orsola-Malpighi Hospital, University of Bologna, 40138 Bologna, Italy (Nieschlag, Zitzmann) Institute of Reproductive Medicine, University Hospital, D-48149 Munster, Germany (Sitruk-Ware) Center for Biomedical Research, Population Council, Rockefeller University, New York, NY 10021, United States (Vogelsong) Development and Research Training in Human Reproduction, Department of Reproductive Health and Research, World Health Organization, 1211 Geneva 27, Switzerland (Wang) Jiangsu Family Planning Research Institute, Jiangsu 210029, China (Wu) Department of Endocrinology, Manchester Royal Infirmary, University of Manchester, Manchester M13 9WL, United Kingdom (Wang) General Clinical Research Center, LABiomed and Harbor-UCLA Medical Center, Torrance, CA 90509, United States (Liu) Department of Andrology, ANZAC Research Institute, University of Sydney and Concord Hospital, Concord, NSW 2139, Australia (Wang) General Clinical Research Center, Harbor-UCLA Medical Center, Los Angeles Biomedical Research Institute, 1000 West Carson Street, Torrance, CA 90509, United Statesen
dc.description.addressP. Y. Liu, Department of Andrology, ANZAC Research Institute, University of Sydney and Concord Hospital, Concord, NSW 2139, Australia. E-mail: pliu@mail.usyd.edu.auen
dc.description.publicationstatusEmbaseen
dc.rights.statementCopyright 2012 Elsevier B.V., All rights reserved.en
dc.identifier.authoremailLiu P.Y.; pliu@mail.usyd.edu.au Wang C.; wang@labiomed.orgen
item.fulltextNo Fulltext-
item.cerifentitytypePublications-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
item.grantfulltextnone-
item.openairetypeArticle-
Appears in Collections:Articles
Show simple item record

Page view(s)

52
checked on Feb 6, 2025

Google ScholarTM

Check


Items in Monash Health Research Repository are protected by copyright, with all rights reserved, unless otherwise indicated.